Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Alpha-1 Antitrypsin Deficiency (A1AD) Clinical trials scenario. This report provides top line data ... Read More
-
Hyperglycemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hyperglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia. Report includes ... Read More
-
Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Diabetic Macular Edema Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Multiple Myeloma (Kahler Disease) Clinical trials scenario. This report provides top line data ... Read More
-
Dementia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia. Report includes ... Read More
-
Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Muscle Invasive Bladder Cancer Clinical trials scenario. This report provides top line ... Read More
-
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 344 million prevalent cases of CLBP in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Chronic pain continues to be a significant global burden despite the availability of a variety of ... Read More
-
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
... UK, Japan, China) and provides an Excel-based forecast model for the Alzheimer's disease market through 2030. Alzheimer's Disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. ... Read More
-
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Rhabdomyosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Rhabdomyosarcoma. Report includes ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data ... Read More
-
Clinical Trials - Impact of COVID-19 and Long COVID
... for these analyses were extracted from GlobalData’s Clinical Trials Database. The data was captured in the database as of April 12, 2023. The data was analyzed and segmented by COVID-19 trials, COVID-19 trials for vaccines ... Read More
-
Global Clinical Trials Market - 2023-2030
... The clinical trials market is expected to exhibit a CAGR of 7.4% during the forecast period (2023-2030). Clinical trials are a methodology of clinical investigation that is overseen by a designated protocol that is carefully ... Read More
-
AI-based Clinical Trial Solution Providers Market Report 2023-2033
... understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Number of Clinical ... Read More
-
Vaccine Contract Manufacturing Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Global Demand, Product Innovation and Cost Effectiveness ... Read More
-
Clinical Trial Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The clinical trial imaging market size is expected ... Read More
-
Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
... Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030 Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 6 million prevalent cases of PsA in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. There are 14 leading marketed drugs for the treatment of PsA, Janssen is the key player in the ... Read More
-
2023 Global Forecast for Life Science Analytics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Computer Systems Design Services industry. The product or service category is within the NAICS Computer Systems Design Services industry. The global market is expected to ... Read More
-
Lewy Body Dementia (LBD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 1.1 million diagnosed prevalent cases of LBD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Currently, there are three marketed products for the treatment of LBD. R&D activity within the LBD ... Read More
-
Short Bowel Syndrome (SBS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... 94,000 diagnosed prevalent cases of SBS in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast. Glucagon-like peptide 2 receptor agonists play a key role in the current treatment paradigm for SBS. R&D activity ... Read More
-
Global Clinical Trials Consumables Market Research Report 2023(Status and Outlook)
... The data generated from these studies help with the approval of the tested drug or medical device. In clinical trials, endpoints are the key results that are expected from the study. Inclusion and exclusion criteria ... Read More
-
Global Clinical Trial Supply and Logistic for Pharmaceutical Market Research Report 2023(Status and Outlook)
... global regulations and available infrastructures. Clinical Trial Supply and Logistic for Pharmaceutical management is imperative for avoiding overproduction, inventory expiration, and oversupply. With the escalating costs of drug discovery, Clinical Trial Supply and Logistic for ... Read More
-
Global Clinical Trial Imaging Market Research Report 2023(Status and Outlook)
... the highest quality specialists with unbiased and professional imaging support. The Global Clinical Trial Imaging Market Size was estimated at USD 1415.00 million in 2022 and is projected to reach USD 2317.15 million by 2029, ... Read More
-
Global CRO in Clinical Trials Market Research Report 2023(Status and Outlook)
... Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, ... Read More
-
Global Clinical Trials Consumables Market Research Report 2023(Status and Outlook)
... The data generated from these studies help with the approval of the tested drug or medical device. In clinical trials, endpoints are the key results that are expected from the study. Inclusion and exclusion criteria ... Read More
Research Assistance
